Bayer R&D Center To Uncover Chinese Insights
Executive Summary
A new dedicated R&D facility for Bayer Consumer Health in China will enable the firm to “quickly take the pulse of the market” and transform demand into innovative products.
You may also be interested in...
Bayer Consumer Health Looks To India And China For New Sources Of Growth
Bayer Consumer Health is stepping up investments in India, China and South East Asia to unleash untapped potential in these high growth OTC markets.
Bayer Hopes Consumer Health Woes Are In Rear View Mirror As Business Returns To Growth
Bayer is starting to see green shoots of recovery after a prolonged period of declining sales and earnings at its Consumer Health business. Turnover improved by 2% in the second quarter, driven by gains in Europe and Latin America.
Bayer Bullish On Consumer Health’s Prospects Despite ‘Challenging’ 2018
Notwithstanding a particularly difficult 2018, Bayer Consumer Health still has "one of the best brand portfolios," and can continue to compete with the market leaders, says CEO Werner Baumann. Consumer Health struggled particularly in the US and Europe in the 12 months, with the majority of its leading brands recording poor performances.